Merck & Co., Inc. (NYSE:MRK)

Major Pharma Sees Fading Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Merck’s Blockbuster Cancer Drug Keytruda Wins Multiple Approvals in Japan

Merck & Co. Inc. (NYSE: MRK) has announced that its blockbuster drug Keytruda received a series of approvals in Japan. The firm said that its anti-PD-1 therapy has simultaneously received ...
Read Full Story »

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

As 2019 gets into gear, there is a simple question that comes with a very difficult answer. Is the bull market that has raged since March of 2009 dead, or ...
Read Full Story »

Meet the 2019 Dogs of the Dow

Investors love their dividends. It was no secret that the bull market’s strength and reputation heading into the end of 2018 was tarnished. In fact, on the last trading day ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Stocks See a Surge in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Health Care Catalysts Coming by the End of 2018

Companies in the health care sector face great risk and great reward every time they make an announcement. Drug candidates passing clinical trials, gaining regulatory approval or being canceled can ...
Read Full Story »

Short Sellers Hike Their Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 6 Most Shorted NYSE Stocks

October turned out to be a very volatile month, with the stock markets seeing a correction and some sectors and many individual stocks slipping into bearish territory. Investors had plenty ...
Read Full Story »

Merck Takes Over as Dow’s Top-Performing Dow Stock

Last week saw the Dow recover a goodly portion of the previous week's loss. The move higher resulted in a change at the top as Merck & Co. Inc. (NYSE: ...
Read Full Story »

Apple, Intel Tank the Dow Friday

November 2, 2018: Markets opened higher Thursday but it didn't take long for word to spread that trade talks between China and the United States were going nowhere. The threat ...
Read Full Story »

Merck Wins Yet Again With New Keytruda Approval

Merck & Co. Inc. (NYSE: MRK) shares were up slightly on Wednesday after the pharma giant gave another key update for its Keytruda line. The firm announced that the U.S. ...
Read Full Story »

Dow Stars Apple and Merck Up Over 25%

The Dow Jones industrial average is up only 1.7% this year to 24,875, a contrast to several years of double-digit improvement. Of the Dow 30 stocks, 12 are down for ...
Read Full Story »

5 Stocks to Move to Now If You Fear a Total Market Crash

This is probably territory most investors are very uncomfortable with. The fears of a massive global trade war just have not been part of the investing lexicon in years, and ...
Read Full Story »